SlideShare a Scribd company logo
High Performance IOL Power Calculation….
at the push of a button
OIS, San Diego
16th
April 2015
Michael Mrochen, CTO and Co Founder
IOL Power Calculation
It takes years of learning and experience!
Google search result on “IOL Power Calculation”
“latest publications”
“previous patient history” “device specific knowledge”
“surgeon specific A-constant”
“Keratometer index”
“Ultra-sound equivalence”
How to match the best outcomes?
NHS Standard
85% within +/- 1D
55% within +/- 0.5D
Royal College of Ophthalmic Cataract Surgeons Guidelines, Gale et al, 2006
More recently
“With modern optical biometry for the majority of
patients, informed formula choice and IOL
constant optimisation outcomes of more than 90%
within ±1 D and more than 60% within ±0.5 D of
target are achievable”.
R.Sheard, Optimising Biometry for best outcomes in cataract surgery, Eye, 2014
To achieve these results takes time for every
patient and considerable expertise
The Problem
• Historical IOL power formulae are:
– Good for the “average” refractive outcome (SEQ)
– Poor for predicting the individual refractive outcome
• High complexity driven by variety of formulae available for
– Short or long eyes
– Astigmatic eyes
– Post-refractive surgery eyes
• Improving refractive outcomes based on formulae requires:
– Experience
– Time to optimize and implement for the individual patient
– Reliable historical clinical data for A-constant optimization
Mirricon –A new Ocular Biometer for
High Performance IOL Power Calculation
•Results at the push of a button assuring:
• Convenience – minimal training time and
improved clinic throughput
•Easy decisions without great expertise and
experience delivering:
• Predictable outcomes - Excellent and
consistent results every time
• Safety – Reducing the possibility of
human error in IOL Power calculation
•One preoperative solution
for all types of eyes
Why is Mirricon different?
Physical Optical Testing
with Model Eyes
Physical Optical Testing
with Model Eyes
First in human useFirst in human use
January 2014
May 2014
May 2015
POC – study in
100 cataract eyes
POC – study in
100 cataract eyes
Status of DevelopmentApril 2014
Device developmentDevice development
Multi Million InvestmentMulti Million Investment
4 patents filed (1 approved)4 patents filed (1 approved)
R&D ProjectR&D Project
2010
What are we looking for?
Partnership opportunities
with IOL and Device
companies
Partnership opportunities
with IOL and Device
companies
Investment partners to
execute our roadmap for
commercialization
Investment partners to
execute our roadmap for
commercialization
Your contacts
Founders
Mirricon - High Performance IOL Power Calculation….
at the push of a button

More Related Content

PPT
DIAGNOSTICS-IMPACT ON THE PREMIUM CHANNEL
PDF
Nexus OAP slide deck
PPTX
The Future of Personalized Implants in Joint Replacement: Additive, Robotics,...
PPT
Capital Budget Presentation
PDF
Acufocus
PPTX
Eye Dropper Concept Presentation
PDF
Paul Sieving
PDF
Second Sight
DIAGNOSTICS-IMPACT ON THE PREMIUM CHANNEL
Nexus OAP slide deck
The Future of Personalized Implants in Joint Replacement: Additive, Robotics,...
Capital Budget Presentation
Acufocus
Eye Dropper Concept Presentation
Paul Sieving
Second Sight

What's hot (20)

PDF
Alcon Google Innovation
PPTX
SPOTLIGHT ON THE PREMIUM CHANNEL – Bausch + Lomb
PDF
Avedro
PDF
Amblyotech
PDF
ICL Corporate Brochure 2016
PDF
The Future of Digital Health and Wearables in Orthopedicsrables
PDF
Allegro
PDF
Questions to Ask BEFORE You Buy a PET/CT Scanner | Atlantis Worldwide
PPT
CRE Medical Final NSF I-Corps Presentation
PPTX
Anterior Segment Company Showcase - AcuFocus
PPTX
SPOTLIGHT ON THE PREMIUM CHANNEL - Alcon
PDF
Special Report: Getting the Optimal Return on X-ray Equipment
PDF
Eleven BioTherapeutics
PDF
Kikinis, Ron - Basic Software Research in Image Guided Therapy
PPTX
Anterior Segment Company Showcase - Z lens
PDF
Gobiquity
PDF
Real-World Evidence: The Future of Data Generation and Usage
PDF
DigiSight Technologies
PDF
Orthopaedic Care Shifts to Outpatient and Urgent Care Clinics
PDF
Power Vision
Alcon Google Innovation
SPOTLIGHT ON THE PREMIUM CHANNEL – Bausch + Lomb
Avedro
Amblyotech
ICL Corporate Brochure 2016
The Future of Digital Health and Wearables in Orthopedicsrables
Allegro
Questions to Ask BEFORE You Buy a PET/CT Scanner | Atlantis Worldwide
CRE Medical Final NSF I-Corps Presentation
Anterior Segment Company Showcase - AcuFocus
SPOTLIGHT ON THE PREMIUM CHANNEL - Alcon
Special Report: Getting the Optimal Return on X-ray Equipment
Eleven BioTherapeutics
Kikinis, Ron - Basic Software Research in Image Guided Therapy
Anterior Segment Company Showcase - Z lens
Gobiquity
Real-World Evidence: The Future of Data Generation and Usage
DigiSight Technologies
Orthopaedic Care Shifts to Outpatient and Urgent Care Clinics
Power Vision
Ad

Viewers also liked (6)

PPT
Holladay2
PPTX
National Ocular Biometry Course (NOBC) 2015 An echoslide presentation
PPTX
Advances in iol calculation
PPT
Biometry: Iol calculation
PPT
PPTX
IOL power calculation formulae
Holladay2
National Ocular Biometry Course (NOBC) 2015 An echoslide presentation
Advances in iol calculation
Biometry: Iol calculation
IOL power calculation formulae
Ad

Similar to High Performance IOL Power Calculation…. at the push of a button (20)

PDF
Clearsight
PPTX
ORA SLIDE DECK with Verifeye For Cataract .pptx
PPTX
Co management with o ds2
PPTX
WTF@OIS: WHAT’S THE FUTURE @OIS?
PPTX
AI for the Human Retina to Protect Newborn Vision
PDF
Data warehousing and analytics for healthcare in practice
PDF
Asia HealthTech Innovation - Philips | The Propell Group
PPTX
IOL POWER CALCULATION IN CHILDREN-Dr.Preetiilal.pptx
PDF
SMi Group's inaugural Ophthalmic Drugs 2017 conference
PDF
Computational Modeling & Simulation in Orthopedics: Tools to Comply in an Ev...
PPTX
OPHTHALMOLOGY INNOVATION SHOWCASE - Cassini
PPTX
strain_analysis major project for phase 2.pptx
PDF
Ophthalmic Drugs 2017
PPTX
PAYING FOR BREAKTHROUGH EYE THERAPIES (BIOLOGICS, BIOSIMILARS & GENE THERAPIE...
PPTX
SPOTLIGHT ON THE PREMIUM CHANNEL – AcuFocus
PPT
ESCRS Presentation
PPT
Population Health Colloquium 2015: Mini Summit IV: Who is Your Champion of Cl...
PDF
How to Pick the Right OCT eBook
PDF
ACT Annual Shareholders' Meeting, October 22, 2013
Clearsight
ORA SLIDE DECK with Verifeye For Cataract .pptx
Co management with o ds2
WTF@OIS: WHAT’S THE FUTURE @OIS?
AI for the Human Retina to Protect Newborn Vision
Data warehousing and analytics for healthcare in practice
Asia HealthTech Innovation - Philips | The Propell Group
IOL POWER CALCULATION IN CHILDREN-Dr.Preetiilal.pptx
SMi Group's inaugural Ophthalmic Drugs 2017 conference
Computational Modeling & Simulation in Orthopedics: Tools to Comply in an Ev...
OPHTHALMOLOGY INNOVATION SHOWCASE - Cassini
strain_analysis major project for phase 2.pptx
Ophthalmic Drugs 2017
PAYING FOR BREAKTHROUGH EYE THERAPIES (BIOLOGICS, BIOSIMILARS & GENE THERAPIE...
SPOTLIGHT ON THE PREMIUM CHANNEL – AcuFocus
ESCRS Presentation
Population Health Colloquium 2015: Mini Summit IV: Who is Your Champion of Cl...
How to Pick the Right OCT eBook
ACT Annual Shareholders' Meeting, October 22, 2013

More from Michael Mrochen (6)

PPTX
Novel biometer first 30 eyes
PPTX
Higher fluence, irradiation profiles, epi on slideshare
PPTX
Clinical results with uvx
PPT
Optical modeling profile
PPT
Cross linking of cornea - a review
PPT
Corneal cross linking with new beam profile
Novel biometer first 30 eyes
Higher fluence, irradiation profiles, epi on slideshare
Clinical results with uvx
Optical modeling profile
Cross linking of cornea - a review
Corneal cross linking with new beam profile

Recently uploaded (20)

PPTX
POLYCYSTIC OVARIAN SYNDROME.pptx by Dr( med) Charles Amoateng
PDF
Neuro ED Bet Sexologist in Patna Bihar India Dr. Sunil Dubey
PPT
genitourinary-cancers_1.ppt Nursing care of clients with GU cancer
PPTX
Neurotransmitter, Types of neurotransmitters,Neurotransmitter function, Neur...
PPTX
post stroke aphasia rehabilitation physician
PPT
OPIOID ANALGESICS AND THEIR IMPLICATIONS
PPTX
1 General Principles of Radiotherapy.pptx
PPTX
neonatal infection(7392992y282939y5.pptx
PPT
ASRH Presentation for students and teachers 2770633.ppt
PDF
CT Anatomy for Radiotherapy.pdf eryuioooop
PPTX
Chapter-1-The-Human-Body-Orientation-Edited-55-slides.pptx
PDF
Deadly Stampede at Yaounde’s Olembe Stadium Forensic.pdf
PPTX
surgery guide for USMLE step 2-part 1.pptx
PPTX
Pathophysiology And Clinical Features Of Peripheral Nervous System .pptx
PDF
Rheumatoid arthritis RA_and_the_liver Prof AbdelAzeim Elhefny Ain Shams Univ...
PPTX
Gastroschisis- Clinical Overview 18112311
PPTX
Respiratory drugs, drugs acting on the respi system
PPTX
ca esophagus molecula biology detailaed molecular biology of tumors of esophagus
PDF
Handout_ NURS 220 Topic 10-Abnormal Pregnancy.pdf
DOCX
RUHS II MBBS Microbiology Paper-II with Answer Key | 6th August 2025 (New Sch...
POLYCYSTIC OVARIAN SYNDROME.pptx by Dr( med) Charles Amoateng
Neuro ED Bet Sexologist in Patna Bihar India Dr. Sunil Dubey
genitourinary-cancers_1.ppt Nursing care of clients with GU cancer
Neurotransmitter, Types of neurotransmitters,Neurotransmitter function, Neur...
post stroke aphasia rehabilitation physician
OPIOID ANALGESICS AND THEIR IMPLICATIONS
1 General Principles of Radiotherapy.pptx
neonatal infection(7392992y282939y5.pptx
ASRH Presentation for students and teachers 2770633.ppt
CT Anatomy for Radiotherapy.pdf eryuioooop
Chapter-1-The-Human-Body-Orientation-Edited-55-slides.pptx
Deadly Stampede at Yaounde’s Olembe Stadium Forensic.pdf
surgery guide for USMLE step 2-part 1.pptx
Pathophysiology And Clinical Features Of Peripheral Nervous System .pptx
Rheumatoid arthritis RA_and_the_liver Prof AbdelAzeim Elhefny Ain Shams Univ...
Gastroschisis- Clinical Overview 18112311
Respiratory drugs, drugs acting on the respi system
ca esophagus molecula biology detailaed molecular biology of tumors of esophagus
Handout_ NURS 220 Topic 10-Abnormal Pregnancy.pdf
RUHS II MBBS Microbiology Paper-II with Answer Key | 6th August 2025 (New Sch...

High Performance IOL Power Calculation…. at the push of a button

  • 1. High Performance IOL Power Calculation…. at the push of a button OIS, San Diego 16th April 2015 Michael Mrochen, CTO and Co Founder
  • 2. IOL Power Calculation It takes years of learning and experience! Google search result on “IOL Power Calculation” “latest publications” “previous patient history” “device specific knowledge” “surgeon specific A-constant” “Keratometer index” “Ultra-sound equivalence”
  • 3. How to match the best outcomes? NHS Standard 85% within +/- 1D 55% within +/- 0.5D Royal College of Ophthalmic Cataract Surgeons Guidelines, Gale et al, 2006 More recently “With modern optical biometry for the majority of patients, informed formula choice and IOL constant optimisation outcomes of more than 90% within ±1 D and more than 60% within ±0.5 D of target are achievable”. R.Sheard, Optimising Biometry for best outcomes in cataract surgery, Eye, 2014 To achieve these results takes time for every patient and considerable expertise
  • 4. The Problem • Historical IOL power formulae are: – Good for the “average” refractive outcome (SEQ) – Poor for predicting the individual refractive outcome • High complexity driven by variety of formulae available for – Short or long eyes – Astigmatic eyes – Post-refractive surgery eyes • Improving refractive outcomes based on formulae requires: – Experience – Time to optimize and implement for the individual patient – Reliable historical clinical data for A-constant optimization
  • 5. Mirricon –A new Ocular Biometer for High Performance IOL Power Calculation •Results at the push of a button assuring: • Convenience – minimal training time and improved clinic throughput •Easy decisions without great expertise and experience delivering: • Predictable outcomes - Excellent and consistent results every time • Safety – Reducing the possibility of human error in IOL Power calculation •One preoperative solution for all types of eyes
  • 6. Why is Mirricon different?
  • 7. Physical Optical Testing with Model Eyes Physical Optical Testing with Model Eyes First in human useFirst in human use January 2014 May 2014 May 2015 POC – study in 100 cataract eyes POC – study in 100 cataract eyes Status of DevelopmentApril 2014 Device developmentDevice development Multi Million InvestmentMulti Million Investment 4 patents filed (1 approved)4 patents filed (1 approved) R&D ProjectR&D Project 2010 What are we looking for? Partnership opportunities with IOL and Device companies Partnership opportunities with IOL and Device companies Investment partners to execute our roadmap for commercialization Investment partners to execute our roadmap for commercialization
  • 8. Your contacts Founders Mirricon - High Performance IOL Power Calculation…. at the push of a button